Michael Nketiah

Michael Nketiah (MBA, RAC) serves as SVP of Regulatory and Clinical Affairs at Subsense Inc., where he leads regulatory strategy for non-surgical neurotechnology medical devices. He has more than 27 years of experience navigating FDA and global regulatory pathways for novel therapeutic technologies.

Posts by Michael Nketiah

MedCity Influencers

Brain Interfaces Don’t Need Surgery to Be Transformative – and the Distinction Is Now a Strategic One

Non-surgical implantable BCI is increasingly capable of matching surgical performance while transforming the risk-benefit equation, and it is now the most credible path along all three dimensions simultaneously.

Michael Nketiah

Posts by Michael Nketiah

Brain Interfaces Don’t Need Surgery to Be Transformative – and the Distinction Is Now a Strategic One

IKS Health Beefs Up Its Tech Stack with $557M Acquisition of TruBridge

ACA Marketplace Insurers Propose 14% Median Premium Increase in 2027

Phase 3 Failure Keeps AstraZeneca and Ionis Out of a Growing Heart Disease Market